Scientists Developed A New Drug To Treat Alzheimer's

The ‘beginning of the end’ for treating Alzheimer’s may be at hand with a new drug developed to treat the cruel disease, according to experts.

Lecanemab, the new drug, is being developed to attack something known as amyloid, which is a protein that builds up in the brains of people who have Alzheimer’s disease, and that’s what Lecanemab targets.

Researchers have conducted clinical trials on the drug and have found that it can be used to slow down the cognitive decline seen in people suffering from Alzheimer’s disease.

According to a study that examined 1,795 people with early Alzheimer’s who were taking Lecanemab for 18 months, the progression of the disease was 27 percent slower in those who took it.

The UK Dementia Research Institute’s director, Bart De Strooper, said one of the current challenges researchers have to face is determining which patients require treatment in order to solve the problem.....

Scribbled Arrow